BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/11/2026 7:19:24 AM | Browse: 61 | Download: 228
 |
Received |
|
2025-09-08 05:21 |
|
Peer-Review Started |
|
2025-09-08 05:21 |
|
First Decision by Editorial Office Director |
|
2025-10-11 07:03 |
|
Return for Revision |
|
2025-10-11 07:03 |
|
Revised |
|
2025-11-10 18:16 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-01-06 02:48 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-01-06 04:35 |
|
Articles in Press |
|
2026-01-06 04:35 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-04 00:32 |
|
Publish the Manuscript Online |
|
2026-02-11 07:19 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Use of Y-90 radioembolization to control liver metastases in pancreatic acinar cell carcinoma and pancreatoblastoma: Two case reports
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Nebojsa Skorupan, David Sperling, Charles Nutting, Markku Miettinen, Allen Cohn and Christine Alewine |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health |
ZIA BC 012041 |
|
| Corresponding Author |
Christine Alewine, Associate Professor, Department of Medicine, Dartmouth Cancer Center, One Medical Center Drive, Williamson 571, Lebanon, NH 03756, United States. christine.alewine@dartmouth.edu |
| Key Words |
Acinar cell carcinoma of the pancreas; Pancreatoblastoma; Yttrium-90 radioembolization; Rare pancreatic tumors; Transarterial radioembolization; Case report |
| Core Tip |
We report the use of Yttrium-90 (Y-90) radioembolization in pancreatic acinar cell carcinoma and adult pancreatoblastoma hepatic metastases. Both patients achieved durable partial responses with multiple Y-90 treatments over extended periods, and tolerated the therapy well. These rare exocrine pancreatic malignancies exhibited marked radiosensitivity, supporting early consideration of Y-90 radioembolization in liver-dominant disease. The successful integration with systemic therapies and ability to repeat treatments safely over multi-year intervals highlights Y-90’s potential as a cornerstone locoregional therapy for these challenging cancers. |
| Publish Date |
2026-02-11 07:19 |
| Citation |
Skorupan N, Sperling D, Nutting C, Miettinen M, Cohn A, Alewine C. Use of Y-90 radioembolization to control liver metastases in pancreatic acinar cell carcinoma and pancreatoblastoma: Two case reports. World J Gastroenterol 2026; 32(8): 113861
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i8/113861.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v32.i8.113861 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
